Disease | acute graft versus host disease |
Comorbidity | C0026986|myelodysplastic syndromes |
Sentences | 1 |
PubMedID- 22952334 | Lenalidomide maintenance after allogeneic hsct seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the lenamaint trial. |
Page: 1